Insider Kevin McNamara signals sale via Form 144 — Chemed (NYSE: CHE)

Rhea-AI Filing Summary

Chemed Corporation reports a Form 144 notice reflecting proposed sales of Common Stock by Kevin McNamara related to stock awards and exercises. The filing lists award/exercise events dated 02/17/2023, 05/01/2023, and 05/02/2023, including awards of 492 and 498 shares.

Insights

Securities Attorney

Form 144 records a proposed Rule 144 sale by an insider; it is an administrative disclosure.

The filing documents a planned sale under Rule 144 of Common Stock by Kevin McNamara tied to prior stock awards and exercises dated 02/17/2023, 05/01/2023, and 05/02/2023. The excerpt lists award quantities such as 492 and 498 shares as examples.

Concrete timing and aggregate sale quantities are not shown in the excerpt. Subsequent filings or broker reports will show actual dispositions; cash‑flow treatment is not specified in the provided excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 5905 E Galbraith Rd, Suite 7000 Cincinnati OH 45236	1000	403820	13765136	03/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2023	Stock Award	Kevin McNamara			492	02/17/2023	Stock Exercise
Common	05/01/2023	Stock Award	Kevin McNamara			498	05/01/2023	Stock Exercise
Common	05/02/2023	Stock Award	Kevin McNamara			10	05/02/2023	Stock Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Chemed's Form 144 filing mean for CHE shareholders?

A Form 144 notice indicates an insider intends to sell shares under Rule 144. It is an administrative disclosure of proposed sales tied to awards/exercises dated 02/17/2023, 05/01/2023, and 05/02/2023 and does not confirm completed sales.

Who is the reported seller in the CHE Form 144 filing?

The filing lists Kevin McNamara as the person associated with the stock awards and exercises. The excerpt shows multiple award/exercise entries tied to his name on 02/17/2023, 05/01/2023, and 05/02/2023.

How many shares are referenced in the Form 144 excerpt for CHE?

The excerpt lists award quantities including 492 and 498 shares as representative examples. The filing text contains additional small award counts but does not present a clear aggregate number for proposed sale.

Does the Form 144 excerpt show proceeds or completed transactions for CHE?

No. The provided excerpt documents proposed sales tied to awards/exercises; it does not disclose sale proceeds or confirm executed dispositions. Actual sale details would appear in subsequent trade reports or amendment filings.